May 26, 2020
Impact of Baseline Dyskinesia on Safety and Efficacy of NOURIANZ® (istradefylline) in Patients with Parkinson's Disease Presented During "Virtual" European Academy of Neurology Meeting
Jan 06, 2020
Kyowa Kirin Announces Marketing Authorisation Application for Istradefylline Validated by European Medicines Agency
Sep 25, 2019
Intec Pharma Highlights Potential of Accordion Pill® Oral Drug Delivery Platform in Two Posters at International Congress of Parkinson's and Movement Disorder Society
Sep 23, 2019
AbbVie to Present New and Updated Data From 22 Abstracts, Including Two Late-Breaking Abstracts for ABBV-951 and DUODOPA® (levodopa/carbidopa intestinal gel), at the International Congress of Parkinson's Disease and Movement Disorders®
Sep 16, 2019
Intec Pharma to Present Two Posters at International Congress of Parkinson's and Movement Disorder Society
Aug 27, 2019
FDA approves new add-on drug to treat off episodes in adults with Parkinson's disease
Jul 24, 2019
Parkinson's Disease Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight
Jul 22, 2019
Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients
Jun 25, 2019
Intec Pharma Announces Results from Earlier Phase 2 Clinical Trial of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients Published in Parkinsonism and Related Disorders
Jun 19, 2019
Intec Pharma Announces Results From Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Were Presented at the XXIV World Congress on Parkinson's Disease and Related Disorders
May 02, 2019
Intec Pharma's Data from Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Accepted for Presentation at the XXIV World Congress on Parkinson's Disease and Related Disorders
Apr 30, 2019
AbbVie to Present New and Updated Data of Investigational Medicines for Parkinson's Disease and Multiple Sclerosis at 2019 American Academy of Neurology Annual Meeting
Apr 30, 2019
Intec Pharma Reports Last Patient Last Visit in Pivotal Phase 3 Trial of Accordion Pill(TM) Carbidopa/Levodopa for the Treatment of Advanced Parkinson's Disease Patients
Feb 19, 2019
Intec Pharma Reports Positive Results from Pharmacokinetic Study of Accordion Pill(TM) Carbidopa/Levodopa 50/500 mg Dosed Three Times Daily
Oct 22, 2018
Intec Pharma Completes Enrollment of Pivotal Phase 3 Clinical Trial of Accordion Pill(TM) Carbidopa/Levodopa for the Treatment of Advanced Parkinson's Disease Patients
Sep 25, 2018
Intec Pharma to Present Multiple Posters at International Congress of Parkinson's and Movement Disorder Society
May 07, 2018
Amneal Initiates Phase 3 Study for IPX203, an Investigational Extended-Release Formulation of Carbidopa-Levodopa (CD-LD) in Advanced Parkinson's Disease Patients
Apr 24, 2018
Intec Pharma Presented Phase 1 PK and Safety Data From Accordion Pill Carbidopa/Levodopa at American Academy of Neurology Annual Meeting
Apr 23, 2018
Parkinson's Disease Therapeutics Market to Exceed the US$ 5.24 Bn by 2025, Says TMR
Apr 04, 2018
Intec Pharma Announces Poster Presentation at American Academy of Neurology Annual Meeting